热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　药师帮（09885）公布2024年业绩，收入约179.04亿元，同比增长5.5%；毛利约18.13亿元，同比增长4.2%；公司拥有人应占利润3001.3万元，同比扭亏为盈；经调整净利润约1.57亿元，同比增长20.1%；每股盈利0.05元。

　　其中，自营业务的收入由截至2023年12月31日止年度的160.36亿元增加至截至2024年12月31日止年度的169.73亿元，主要归因于买家群体扩大以及物流及客户服务等买家体验持续优化。自营业务的月付费买家数量比去年同期持续稳定增加。

　　平台业务的收入略增至8.81亿元，主要归因于佣金率提高。报告期内，第三方卖家的佣金率由去年同期的3.2%略微上升至3.3%，原因为平台业务中收取高费率业务的占比增加。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.